Companies/CN/300289

利德曼 · BEIJING LEADMAN BIOCHEMISTRY CO.,LTD.

Income flow

Annual
300289 10-K Income StatementPeriod 2025-12-31Source 10-K
Net salesCNY 326M-12% Y/YRevenueCNY 326M-12% Y/YGross profitCNY 163MCost of revenueCNY 163M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · CNY
By activity
By activityCNY 326M
  • 体外诊断试剂CNY 240M73.6%
  • 房屋租赁CNY 39M11.8%
  • 诊断仪器CNY 32M9.9%
  • 生物化学原料CNY 13M4.1%
  • 服务CNY 2M0.7%
By geography
By geographyCNY 326M
  • 华东地区CNY 136M41.6%
  • 华北地区CNY 80M24.5%
  • 华南地区CNY 42M12.8%
  • 华中地区CNY 38M11.8%
  • 东北地区CNY 14M4.2%
  • 西南地区CNY 9M2.7%
  • 西北地区CNY 8M2.5%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.17.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.1250.0%Shares outTotal shares currently outstanding (issued and not retired).544.0MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).290.7M
Dividend calendar
Ex-dividend
2024-05-17
Last cash
0.01 · 2024-05-17
Stock splits
  1. 25:102015-10-27

Valuation

Trailing PE 164.7 (2023-12-31)PE trend

Fiscal PE1

PeriodEPSClosePE
2023-12-310.034.94164.7

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.